Cellectar Biosciences, Inc. — Director's Dealing 2020

Jan 8, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cellectar Biosciences, Inc. (CLRB)
CIK: 0001279704
Period of Report: 2020-01-06

Reporting Person: Grachev Igor D (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-01-06	Stock Option (right to buy)	$2.46	A	80000	Acquired	2030-01-06	Common Stock (80000)	Direct

Footnotes

F1: Options vest in equal annual increments over a period of three years from the date of grant.